LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

(1) Recognize when to refer patients for stem cell and cellular therapy.

(2) Discuss the outcomes utilizing alternate donors for stem cell transplantation (haploidentical donors).

(3) Identify the familiarity role for CAR-T (Chimeric antigen receptor T-cell) therapy.

FACULTY DISCLOSURE: Robert Berryman, MD, has relevant financial relationship(s) with Karyopharm, Genzyme, and GSK as a speaker and receives a honoraria.

PLANNER DISCLOSURE: Jennifer Zimmer, MD and Jamie Davidson have no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For assistance please contact Jamie Davidson at [email protected]